Bio-Techne (TECH) Competitors

Bio-Techne (NASDAQ:TECH) and Bruker (NASDAQ:BRKR) are both mid-cap life sciences tools & services companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

Do insiders & institutionals believe in TECH or BRKR?

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 3.9% of Bio-Techne shares are owned by insiders. Comparatively, 27.3% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk and volatility, TECH or BRKR?

Bio-Techne has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500.

Is TECH or BRKR more profitable?

Bio-Techne has a net margin of 10.89% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	10.89%	13.17%	10.17%
Bruker	2.31%	19.47%	5.95%

Does the media refer more to TECH or BRKR?

In the previous week, Bio-Techne had 15 more articles in the media than Bruker. MarketBeat recorded 22 mentions for Bio-Techne and 7 mentions for Bruker. Bruker's average media sentiment score of 1.16 beat Bio-Techne's score of 0.89 indicating that Bruker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	11 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Bruker	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer TECH or BRKR?

Bio-Techne presently has a consensus price target of $70.00, indicating a potential upside of 35.13%. Bruker has a consensus price target of $52.89, indicating a potential upside of 27.44%. Given Bio-Techne's stronger consensus rating and higher probable upside, research analysts clearly believe Bio-Techne is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	0 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Bruker	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40

Is TECH or BRKR a better dividend stock?

Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Bio-Techne pays out 39.0% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Which has higher earnings and valuation, TECH or BRKR?

Bio-Techne has higher earnings, but lower revenue than Bruker. Bio-Techne is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.16B	7.01	$168.10M	$0.82	63.17
Bruker	$3.45B	1.82	$113.10M	$0.52	79.81

Summary

Bio-Techne beats Bruker on 12 of the 18 factors compared between the two stocks.